申请人:Sankyo Company, Limited
公开号:US05604256A1
公开(公告)日:1997-02-18
Compounds of formula (I): ##STR1## (in which: R is hydrogen, methyl or hydroxy; X is alkyl, alkenyl, cycloalkyl, aryl, aralkyl, or a heterocyclic group; A is a single bond, or an alkylene, alkenylene, alkynylene or alkadienylene group; Y is hydrogen, aryl, cycloalkyl or a heterocyclic group) have the ability to inhibit the biosynthesis of cholesterol, and can thus be used for the treatment and prophylaxis of diseases relating to high blood cholesterol levels.
式(I)的化合物:##STR1## (其中:R为氢,甲基或羟基;X为烷基,烯基,环烷基,芳基,芳基烷基或杂环基;A为单键,或烷基,烯基,炔基或烯炔基;Y为氢,芳基,环烷基或杂环基)具有抑制胆固醇生物合成的能力,因此可用于治疗和预防与高血胆固醇水平有关的疾病。